IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Aliskiren, an Oral Direct Renin Inhibitor, is Effective and Well Tolerated Compared to Ramipril in Asian Patients with Mild-to-Moderate Hypertension
Sun, Ningling1; Zhu, Junren2; He, Qing3; Cai, Naisheng2; Zhu, Dingliang4; Wang, Ruonan5; Tu, Yingmei5; Ritter, Shannon6; Keefe, Deborah6
刊名CIRCULATION
2010-07-13
122期:2页:E168-E168
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems ; Peripheral Vascular Disease
研究领域[WOS]Cardiovascular System & Cardiology
语种英语
WOS记录号WOS:000279801702257
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63973
专题北京大学第二临床医学院
作者单位1.Beijing Hosp, Beijing, Peoples R China
2.Beijing Novartis Pharma Co Ltd, Beijing, Peoples R China
3.Novartis Pharmaceut, E Hanover, NJ USA
4.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
5.Fudan Univ, Zhong Shan Hosp, Shanghai 200433, Peoples R China
6.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China
推荐引用方式
GB/T 7714
Sun, Ningling,Zhu, Junren,He, Qing,et al. Aliskiren, an Oral Direct Renin Inhibitor, is Effective and Well Tolerated Compared to Ramipril in Asian Patients with Mild-to-Moderate Hypertension[J]. CIRCULATION,2010,122(2):E168-E168.
APA Sun, Ningling.,Zhu, Junren.,He, Qing.,Cai, Naisheng.,Zhu, Dingliang.,...&Keefe, Deborah.(2010).Aliskiren, an Oral Direct Renin Inhibitor, is Effective and Well Tolerated Compared to Ramipril in Asian Patients with Mild-to-Moderate Hypertension.CIRCULATION,122(2),E168-E168.
MLA Sun, Ningling,et al."Aliskiren, an Oral Direct Renin Inhibitor, is Effective and Well Tolerated Compared to Ramipril in Asian Patients with Mild-to-Moderate Hypertension".CIRCULATION 122.2(2010):E168-E168.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Sun, Ningling]的文章
[Zhu, Junren]的文章
[He, Qing]的文章
百度学术
百度学术中相似的文章
[Sun, Ningling]的文章
[Zhu, Junren]的文章
[He, Qing]的文章
必应学术
必应学术中相似的文章
[Sun, Ningling]的文章
[Zhu, Junren]的文章
[He, Qing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。